Arriaza Arriaza

Dr. Arriaza Arriaza


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 January 2025 in Genes
Verified
Journal Article
Open access
PDF file
VDVanessa Díaz
Vanessa Díaz
MVMaite Villalobos
Maite Villalobos
AAArriaza Arriaza
Arriaza Arriaza
KFKaren Flores
Karen Flores
LHLucas Patricio Hernández-Saravia
Lucas Patricio Hernández-Saravia
AVAlexis Velásquez
Alexis Velásquez
Arbuscular mycorrhizal (AM) symbiosis, a mutually beneficial interaction between plant roots and AM fungi, plays a key role in plant growth, nutrient acquisition, and stress tolerance, which make it a major focus for sustainable agricultural strategies. This intricate association involves extensive transcriptional reprogramming in host plant cells during the formation of arbuscules, which are specialized fungal structures for nutrient exchange. The symbiosis is initiated by molecular signaling pathways triggered by fungal chitooligosaccharides and strigolactones released by plant roots, which act as chemoattractants and signaling molecules to promote fungal spore germination, colonization, and arbuscule development. Calcium spiking, mediated by LysM domain receptor kinases, serves as a critical second messenger in coordinating fungal infection and intracellular accommodation. GRAS transcription factors are key components that regulate the transcriptional networks necessary for arbuscule development and maintenance, while small RNAs (sRNAs) from both plant and fungi, contribute to modifications in gene expression, including potential bidirectional sRNA exchange to modulate symbiosis. Understanding the molecular mechanisms related to AM symbiosis may provide valuable insights for implementation of strategies related to enhancing plant productivity and resilience.

Verified
Journal Article
Open access
PDF file
Eduardo PenaEduardo Pena
Eduardo Pena
RMRocio San Martin-Salamanca
Rocio San Martin-Salamanca
Samia El AlamSamia El Alam
Samia El Alam
KFKaren Flores
Karen Flores
AAArriaza Arriaza
Arriaza Arriaza
Tauopathies are a group of neurodegenerative diseases whose central feature is dysfunction of the microtubule-associated protein tau (MAPT). Although the exact etiology of tauopathies is still unknown, it has been hypothesized that their onset may occur up to twenty years before the clear emergence of symptoms, which has led to questions about whether the prognosis of these diseases can be improved by, for instance, targeting the factors that influence tauopathy development. One such factor is hypoxia, which is strongly linked to Alzheimer’s disease because of its association with obstructive sleep apnea and has been reported to affect molecular pathways related to the dysfunction and aggregation of tau proteins and other biomarkers of neurological damage. In particular, hypobaric hypoxia exposure increases the activation of several kinases related to the hyperphosphorylation of tau in neuronal cells, such as ERK, GSK3β, and CDK5. In addition, hypoxia also increases the levels of inflammatory molecules (IL-β1, IL-6, and TNF-α), which are also associated with neurodegeneration. This review discusses the many remaining questions regarding the influence of hypoxia on tauopathies and the contribution of high-altitude exposure to the development of these diseases.

Verified
Journal Article
Open access
PDF file
KFKaren Flores
Karen Flores
CACarlo Almeida
Carlo Almeida
AAArriaza Arriaza
Arriaza Arriaza
Eduardo PenaEduardo Pena
Eduardo Pena
Samia El AlamSamia El Alam
Samia El Alam
The pathophysiology of pulmonary hypertension is complex and multifactorial. It is a disease characterized by increased pulmonary vascular resistance at the level due to sustained vasoconstriction and remodeling of the pulmonary arteries, which triggers an increase in the mean pulmonary artery pressure and subsequent right ventricular hypertrophy, which in some cases can cause right heart failure. Hypoxic pulmonary hypertension (HPH) is currently classified into Group 3 of the five different groups of pulmonary hypertensions, which are determined according to the cause of the disease. HPH mainly develops as a product of lung diseases, among the most prevalent causes of obstructive sleep apnea (OSA), chronic obstructive pulmonary disease (COPD), or hypobaric hypoxia due to exposure to high altitudes. Additionally, cardiometabolic risk factors converge on molecular mechanisms involving overactivation of the mammalian target of rapamycin (mTOR), which correspond to a central axis in the development of HPH. The aim of this review is to summarize the role of mTOR in the development of HPH associated with metabolic risk factors and its therapeutic alternatives, which will be discussed in this review.

15 December 2025 in Nutrients
Verified
Journal Article
Open access
PDF file
JTJorge Hernán Torres-Mejías
Jorge Hernán Torres-Mejías
AAArriaza Arriaza
Arriaza Arriaza
FMFrancisco Mena
Francisco Mena
EREvangelina Rivarola
Evangelina Rivarola
PPPatricio Paredes
Patricio Paredes
EMEugenio Merellano-Navarro
Eugenio Merellano-Navarro
Background/Objectives: Intermittent hypobaric hypoxia (IHH) induces various physiological and metabolic adaptations. This study aimed to investigate the effects of a seven-day IHH exposure on nutritional status, body composition, gut microbiota, movement intensity, and energy expenditure in 10 workers. Methods: A pre–post comparative design was employed, with measurements taken at the beginning and end of the exposure period. Nutritional status, body composition, and phase angle (PhA) were assessed via bioelectrical impedance analysis (BIA). Gut microbiota composition was analyzed through fecal DNA extraction and qPCR for specific bacterial families. Movement intensity and energy expenditure were monitored using accelerometry. An initial statistical analysis was performed, which included paired t-tests and Wilcoxon signed-rank tests. Results: A significant increase in PhA (mean difference: 0.40; p = 0.0053 for t-test, p = 0.0136 for Wilcoxon) and a significant decrease in BMI (mean difference: −0.38; p = 0.0311 for t-test, p = 0.0546 for Wilcoxon). Conclusions: While the original paper reported no significant changes in nutritional status or body composition, our re-analysis suggests a significant change in BMI. The original paper also reported significant changes in specific gut bacterial families (butyrate-producing bacteria, p = 0.037; Lactobacillus species, p = 0.006). Physical activity levels remained consistently low.

24 March 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Eduardo PenaEduardo Pena
Eduardo Pena
Samia El AlamSamia El Alam
Samia El Alam
KFKaren Flores
Karen Flores
AAArriaza Arriaza
Arriaza Arriaza
Patricia SiquesPatricia Siques
Patricia Siques
MCMário de Castro
Mário de Castro
Background/Objectives: Long-term chronic intermittent hypobaric hypoxia (CIHH) is a common occupational exposure among high-altitude workers, particularly miners in northern Chile. This condition consists of working several days above 2500 m followed by rest at sea level, maintaining this cycle for years, which generates physiological alterations. This study analyzed associations among anthropometric indices and biomedical conditions in miners chronically exposed to long-term CIHH. Methods: This study was a cross-sectional analysis of 120 healthy Chilean male miners working at altitudes above 4400 m under a 7-day work/7-day rest schedule. Eligibility required ≥5 years of CIHH exposure and absence of cardiopulmonary disease, hypertension, diabetes, or oxygen therapy use. The assessments at altitude included oxygen saturation (SpO2), blood pressure, heart rate, hematological parameters, metabolic parameters, and waist-to-hip ratio (WHR); measurements were obtained 18 h after arrival at altitude. WHR, BMI, SpO2, and biomedical variables were collected following standardized procedures. Descriptive statistics and group comparisons were performed with Student’s t-test or the Wilcoxon test, with statistical significance set at p < 0.05. Normality assumption was assessed using the Shapiro–Wilk test. The association between WHR and SpO2 was estimated using linear regression, with WHR scaled so that one unit corresponds to a 0.1-unit increase. Adjusted models included BMI, age, and years working under CIHH. Effect sizes and 95% confidence intervals (CIs) were reported. All statistical analyses were performed in the R programming language. Results: Mean SpO2 was 89.07 ± 0.50% and mean WHR was 0.94 ± 0.01. In unadjusted comparisons, workers with WHR > 0.94 had lower SpO2 than those below the threshold (88.8 ± 0.54 vs. 90.41 ± 0.50; p = 0.031). In adjusted models, the WHR–SpO2 association was small and imprecise (β per 0.1-unit WHR = −0.67 pp; 95% CI −2.08 to 0.74). Hemoglobin showed an independent association with SpO2, while other metabolic variables did not materially contribute. Conclusions: SpO2 showed a modest inverse association with WHR in long-term CIHH workers. Even small saturation decreases may matter at high altitude. Combined WHR–SpO2 monitoring may aid occupational surveillance, though longitudinal studies are needed to establish meaningful risk thresholds.

Verified
Journal Article
Open access
PDF file
KFKaren Flores
Karen Flores
AAArriaza Arriaza
Arriaza Arriaza
Samia El AlamSamia El Alam
Samia El Alam
PPPatricia Michel Perez
Patricia Michel Perez
Eduardo PenaEduardo Pena
Eduardo Pena
Currently, the number of people living and engaging in activities at high altitude is steadily increasing. Consequently, the physiological effects of altitude exposure have been extensively investigated to protect the health of individuals exposed to these extreme environmental conditions, alongside a notable increase in female participation driven by expanding opportunities in occupational, athletic, and residential settings. In addition to established risk factors, growing evidence suggests that cardiometabolic risk factors may increase the likelihood of developing altitude-related illnesses, while women present sex-specific physiological characteristics that contribute to metabolic disorders, including the menstrual cycle, contraceptive use, pregnancy, and menopause. Furthermore, factors such as hypobaric hypoxia, the type of activity performed at altitude, lifestyle, and emotional status may result in distinct physiological responses to altitude. However, little is known about the physiological adaptations experienced by women at high altitude, particularly regarding metabolic alterations that may contribute to impaired acclimatization. Therefore, this review synthesizes current evidence on the role of cardiometabolic risk factors and associated determinants in the development and exacerbation of altitude-related illnesses in women, aiming to identify existing knowledge gaps, guide future research, and improve prevention, acclimatization, clinical management, and women’s health and safety in high-altitude environments through a comprehensive assessment of current evidence.